Genetic Analysis AS (XSAT:GEAN)
Sweden
· Delayed Price · Currency is SEK · Price in NOK 0.630
-0.010 (-1.56%)
At close: Apr 28, 2026
Genetic Analysis AS Market Cap
Genetic Analysis AS has a market cap or net worth of 43.30 million as of April 29, 2026. Its market cap has increased by 31.58% in one year.
Market Cap
43.30M
Enterprise Value
25.76M
Revenue
19.36M
Ranking
n/a
PE Ratio
n/a
Stock Price
0.63
Market Cap Chart
Since October 1, 2021, Genetic Analysis AS's market cap has decreased from 235.48M to 43.30M, a decrease of -81.61%. That is a compound annual growth rate of -30.94%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 28, 2026 | 43.30M | -2.23% |
| Dec 30, 2025 | 44.29M | 81.07% |
| Dec 30, 2024 | 24.46M | -31.37% |
| Dec 29, 2023 | 35.64M | -34.69% |
| Dec 30, 2022 | 54.57M | -66.71% |
| Dec 30, 2021 | 163.91M | -30.39% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Touchtech AB | 40.35M |
| EcoRub AB | 39.87M |
| Redsense Medical AB | 49.17M |
| Gomero Group AB | 36.46M |
| Vidhance AB | 35.90M |
| Kontigo Care AB | 55.70M |
| MoveByBike Europe AB | 59.03M |
| Lightning Group AB | 31.13M |